Association between autoimmune thyroiditis and BRAFV600E/TERT promoter mutations in patients with papillary thyroid carcinoma from Central Asia, Kazakhstan
PLOS One · 20.07.2026 · 21 (7) · e0351960
DOI: 10.1371/journal.pone.0351960 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift PLOS One, online erschienen am 20.07.2026. Verfasst von Saya Kaidarova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Semey Medical University, Semey, Kazakhstan. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Promoter Regions, Genetic, Telomerase, Thyroid Neoplasms. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Atomic Bomb Disease Institute, Nagasaki University and the Program of the Network-Type Joint Usage/Research Center for Radiation Disaster Medical Science.
Abstract (Originalsprache)
Background
Autoimmune thyroiditis (AIT), including Hashimoto’s thyroiditis (HT) and Graves’ disease (GD), frequently coexists with papillary thyroid carcinoma (PTC). Chronic inflammation may influence thyroid carcinogenesis; however, the relationship between AIT and aggressive molecular alterations in PTC, particularly BRAFV600E and TERT promoter mutations, remains unclear. Data from iodine-deficient regions such as Kazakhstan are limited.
Methods
We conducted a retrospective multicenter study of 231 patients with PTC from Kazakhstan treated between 2016 and 2020. Tumors were reclassified according to the World Health Organization 5th edition (2022). Clinicopathological characteristics, AIT status (HT and GD), BRAFV600E and TERT promoter mutation profiles, and proliferative activity (Ki-67) were analyzed. Associations between AIT, molecular alterations, and clinicopathological features were evaluated.
Results
Most patients were female (83.1%) and
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Semey Medical University, Semey, Kazakhstan.
- Nagasaki University, Atomic Bomb Disease Institute, Nagasaki, Japan.
- Al-Farabi Kazakh National University, Almaty, Kazakhstan.
- Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan.
ORCID-Profile: Zhanna Mussazhanova
Förderung
- Atomic Bomb Disease Institute, Nagasaki University and the Program of the Network-Type Joint Usage/Research Center for Radiation Disaster Medical Science
Zitieren
APA
Kaidarova, S., Mussazhanova, Z., Kozykenova, Z., Kurohama, H., Targynova, A., Dyussupov, A., Yeleubayeva, Z., & Nakashima, M. (2026). Association between autoimmune thyroiditis and BRAFV600E/TERT promoter mutations in patients with papillary thyroid carcinoma from Central Asia, Kazakhstan. PLOS One, 21(7), e0351960. https://doi.org/10.1371/journal.pone.0351960
Vancouver
Kaidarova S, Mussazhanova Z, Kozykenova Z, Kurohama H, Targynova A, Dyussupov A, et al. Association between autoimmune thyroiditis and BRAFV600E/TERT promoter mutations in patients with papillary thyroid carcinoma from Central Asia, Kazakhstan. PLOS One. 2026;21(7):e0351960. doi:10.1371/journal.pone.0351960
BibTeX
@article{Kaidarova2026,
author = {Kaidarova, Saya and Mussazhanova, Zhanna and Kozykenova, Zhanna and Kurohama, Hirokazu and Targynova, Akbota and Dyussupov, Altay and Yeleubayeva, Zhanar and Nakashima, Masahiro},
title = {Association between autoimmune thyroiditis and BRAFV600E/TERT promoter mutations in patients with papillary thyroid carcinoma from Central Asia, Kazakhstan},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {7},
pages = {e0351960},
doi = {10.1371/journal.pone.0351960}
}
EUVIMED